American Society of Gene Therapy | 10th Annual Meeting


	ASGT 10th Annual Meeting May 30 - June 3, 2007 Washington State Convention & Trade Center · Seattle, WA · USA
Final Program \| 10th Anniversary Symposium \| Supporters \| 10th Annual Meeting Home \| ASGT Home

General Evaluation

Meeting Objectives

At the completion of this meeting, the participant should be able to: 1) Discuss the key aspects of current laboratory and/or clinical research in gene therapy; 2) Demonstrate knowledge of methods being used by gene therapy researchers and practitioners; 3) Describe one or more stimulating new areas of inquiry in the area of gene therapy; and, 4) Demonstrate familiarity with federal regulations and guidelines for clinical gene transfer studies.

Please answer the following by checking a number. Your feedback is needed and greatly appreciated by the Society.

	Excellent	Good	Average	Poor	Very Poor	Not Sure or n/a
1. The meeting met the stated objectives above.
2. Relevancy of the meeting to the study of gene therapy.
3. Methods used by researchers.
4. Access to faculty and presenters.
5. Quality of Wednesday Early-Bird Sessions.
6. Quality of Wednesday Education Program.
	Excellent	Good	Average	Poor	Very Poor	Not Sure or n/a
7. Presentation of oral abstracts.
8. Topics of poster sessions.
9. Visual appearance of posters at poster sessions.
10. Exhibitor products and services displayed at meeting.
11. Exhibitor hours available to attendees.
12. Final Program.
	Excellent	Good	Average	Poor	Very Poor	Not Sure or n/a
13. Schedule-At-A-Glance.
14. Quality of Executive Summary.
15. ASGT Registration Process.
16. Washington State Convention & Trade Center facilities.
17. Abstract submission process.
18. Helpfulness of Job Exchange Area.
19. Prior to the meeting, did you access the ASGT Website for meeting information?					Yes	No
20. Did you find the Website useful?					Yes	No

21. What changes would you suggest for the future to make the ASGT Annual Meeting more beneficial and useful to you?
22. What topics would you like to see addressed at future ASGT meetings?
23. Other Comments